HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transcatheter Aortic Valve Replacement for Aortic Regurgitation Caused by Takayasu Arteritis.

Abstract
Aortic regurgitation (AR) in patients with Takayasu arteritis is considered a relatively common clinical condition. Aortic valve replacement as a surgical treatment, however, is known to have a high risk of postoperative prosthetic valve detachment or anastomotic pseudoaneurysm. This pilot study reports on an initial experience with transcatheter aortic valve replacement (TAVR) for AR caused by Takayasu arteritis. The outcome suggests that TAVR may be a potentially feasible alternative treatment option for AR in Takayasu arteritis, especially in relatively older and vulnerable patients.
AuthorsJinmiao Chen, Yuntao Lu, Ye Yang, Xiufang Kong, Chunsheng Wang, Lai Wei
JournalThe Annals of thoracic surgery (Ann Thorac Surg) Vol. 114 Issue 2 Pg. e145-e148 (08 2022) ISSN: 1552-6259 [Electronic] Netherlands
PMID34896414 (Publication Type: Journal Article)
CopyrightCopyright © 2022 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Topics
  • Aortic Valve (surgery)
  • Aortic Valve Insufficiency (etiology, surgery)
  • Aortic Valve Stenosis (surgery)
  • Heart Valve Prosthesis (adverse effects)
  • Heart Valve Prosthesis Implantation (adverse effects)
  • Humans
  • Pilot Projects
  • Risk Factors
  • Takayasu Arteritis (complications, surgery)
  • Transcatheter Aortic Valve Replacement (adverse effects)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: